Working… Menu

Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00068302
Recruitment Status : Terminated (Recruiting/enrolling participants halted prematurely but potentially will resume)
First Posted : September 11, 2003
Last Update Posted : March 12, 2015
National Childhood Cancer Foundation
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Children's Hospital of Philadelphia

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 2009
Actual Study Completion Date : July 2013